Adverse events (AEs) with maintenance olaparib tablets in patients (pts) with BRCA-mutated (BRCAm) platinum-sensitive relapsed serous ovarian cancer (PSR SOC …
JA Ledermann, A Lortholary, RT Penson, E Gibbs… - 2017 - ascopubs.org
5518 Background: In the SOLO2 trial (ENGOT Ov-21; NCT01874353), maintenance therapy
with the PARP inhibitor olaparib significantly improved PFS vs placebo (PBO) in BRCA m …
with the PARP inhibitor olaparib significantly improved PFS vs placebo (PBO) in BRCA m …